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Mutations in KCNK4 that Affect Gating
Cause a Recognizable Neurodevelopmental Syndrome
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Aberrant activation or inhibition of potassium (Kþ) currents across the plasma membrane of cells has been causally linked to altered
neurotransmission, cardiac arrhythmias, endocrine dysfunction, and (more rarely) perturbed developmental processes. The Kþ channel
subfamily K member 4 (KCNK4), also known as TRAAK (TWIK-related arachidonic acid-stimulated Kþ channel), belongs to the
mechano-gated ion channels of the TRAAK/TREK subfamily of two-pore-domain (K2P) Kþ channels.While K2P channels are well known
to contribute to the resting membrane potential and cellular excitability, their involvement in pathophysiological processes remains
largely uncharacterized. We report that de novo missense mutations in KCNK4 cause a recognizable syndrome with a distinctive facial
gestalt, for which we propose the acronym FHEIG (facial dysmorphism, hypertrichosis, epilepsy, intellectual disability/developmental
delay, and gingival overgrowth). Patch-clamp analyses documented a significant gain of function of the identified KCNK4 channel
mutants basally and impaired sensitivity to mechanical stimulation and arachidonic acid. Co-expression experiments indicated a
dominant behavior of the disease-causing mutations. Molecular dynamics simulations consistently indicated that mutations favor
sealing of the lateral intramembrane fenestration that has been proposed to negatively control Kþ flow by allowing lipid access to
the central cavity of the channel. Overall, our findings illustrate the pleiotropic effect of dysregulated KCNK4 function and provide
support to the hypothesis of a gating mechanism based on the lateral fenestrations of K2P channels.The human genome contains almost 80 genes encoding
potassium (Kþ) channels, which constitute the most diver-
sified class of ion channels with regard to structure and
gating characteristics (see OMIM database). Such diversity
allows Kþ channels to serve various functions in both
excitable and non-excitable cells.1–3 Kþ channels
contribute to the maintenance and stabilization of the
resting membrane potential, help to repolarize action po-
tentials, mediate hyperpolarization, and determine cellular
electrical activity or even cell proliferation. Moreover, Kþ
channels also efficiently mediate modulations of mem-
brane potential and cell function by controlling the Kþ
flux through the cell membrane in response to multiple
signals. Since the membrane potential has a key role in
the control of a wide array of cellular processes, including
cellular excitability, neurotransmitter release, hormone
secretion, and electrolyte transport, it is not surprising
that aberrant or impaired Kþ flux due to hyperactivating
or inactivating mutations in genes coding for Kþ channels
underlies a heterogeneous spectrum of human disorders
affecting neurotransmission and central nervous system
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 2018 American Society of Human Genetics.and kidney function.2,4–6 Remarkably, the aberrant func-
tion of some of these channels has recently been docu-
mented to affect development and underlie syndromic
disorders.7–11 Here, we report on the identification of
dominantly acting mutations in KCNK4 (MIM: 605720),
which encodes a two-pore-domain (K2P) Kþ channel,12–14
as the cause of a previously unrecognized syndrome having
a distinctive facial gestalt, gingival overgrowth, hypertri-
chosis, intellectual disability, and epilepsy as major
features. KCNK4, also known as TRAAK (TWIK-related
arachidonic acid-stimulated Kþ channel), is one of three
lipid- and mechano-sensitive K2P channels constituting
the TRAAK/TREK subfamily. We provide data indicating
that the disease-causing mutations are activating basally
and cause impaired sensitivity to mechanical stimuli and
arachidonic acid. Finally, we offer molecular dynamics
data suggesting the structural mechanism by which these
mutations exert their gain of function, providing support
to the hypothesis of a gating mechanism based on the
lateral fenestrations of K2P channels.
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Figure 1. Clinical Features of Individuals
with De Novo KCNK4 Mutations
(A–C) Subject 1 (11 months). Note the hy-
potonic face, bitemporal narrowing, bushy
and straight eyebrows, long eyelashes,
short deep philtrum, prominent upper
and lower vermilion, and receding chin.
(D–F) Subject 2 at 12 months and 5 years.
Evolution of facial appearance is appre-
ciable. Note the bitemporal narrowing,
bushy and straight eyebrows, long eye-
lashes, low-set anteverted ears, short deep
philtrum, and prominent upper and lower
vermilion.
(G–I) Subject 3 at 8 years. Long eyebrows
with mild synophris and long eyelashes,
thick hair, large mouth with smooth phil-
trum, and thin lips can be appreciated.
Gingival overgrowth and generalized
hypertrichosis occur in all affected individ-
uals with different degree of severity.Ospedale Pediatrico Bambino Gesu`, Rome, the exomes of
two unrelated subjects with a molecularly unexplained,
clinically superimposable phenotype were scanned to
identify the underlying molecular cause. Clinical data
and DNA samples were collected from the participating
families after written informed consent was obtained, and
they were stored and used according to the Institutional
Review Board recommendations. In both children, the
unusual core of features included variable developmental
delay, distinctive facies, gingival overgrowth, hypertricho-
sis, and EEG anomalies/epilepsy (Figure 1, Table 1, Supple-
mental Note). Whole-exome sequencing (WES) used DNA
samples obtained from leukocytes. Exome capture was
attained using the SureSelect Clinical Research Exome v.2
(subject 1) and Nextera v.1.2 (subject 2 and both parents)
target enrichment kits, and sequencing was performed on622 The American Journal of Human Genetics 103, 621–630, October 4, 2018a NextSeq500, using paired-end reads.
WES data processing, sequence align-
ment to GRCh37, variant filtering
and prioritization by allele frequency,
predicted functional impact, and in-
heritance models were performed us-
ing an in-house implemented pipe-
line, as previously described.15–17
Briefly, reads were aligned to human
genome build GRCh37/UCSC hg19
and variants were quality filtered ac-
cording to GATK’s 2016 best practices,
annotated, and filtered against public
(dbSNP150 and gnomAD v.2.0)
and in-house (>1,300 population-
matched exomes) databases to retain
private and rare (unknown frequency
or MAF < 0.1%) variants located in
exons with any effect on the coding
sequence, and within splice site
regions. The functional impact ofvariants was analyzed by Combined Annotation Depen-
dent Depletion (CADD) v.1.3, M-CAP v.1.0, and InterVar
v.0.1.6 algorithms18–20 to obtain clinical interpretation ac-
cording to ACMG 2015 guidelines.21 WES data output is
reported in Table S1. Two variants in KCNK4 (subject 1:
GenBank: NM_001317090.1; c.515C>A [p.Ala172Glu];
subject 2: GenBank: NM_001317090.1; c.730G>C
[p.Ala244Pro]), compatible with autosomal-dominant
transmission of the trait, were identified as the only shared
events. Both variants were confirmed to occur as de novo
events by Sanger sequencing. STR analysis confirmed
paternity in family 1, and mutation analysis performed on
primary skin fibroblasts and hair bulb epithelial cells of
both affected subjects supported the germline origin of
mutations. One additional subject born to unaffected
parents, sharing a similar gestalt, intellectual disability
Table 1. Clinical Features of the Three Subjects with De Novo KCNK4 Mutations
Subject 1 Subject 2 Subject 3
Sex M M F
Age at last evaluation 11 m 5 years 7 m 8 years
KCNK4 mutation (NM_001317090.1) c.515C>A (p.Ala172Glu) c.730G>C (p.Ala244Pro) c.515C>A (p.Ala172Glu)
Inheritance simplex case, de novo simplex case, de novo simplex case, de novo
Pregnancy history uneventful uneventful uneventful
Neonatal feeding/swallowing problems þ  þ
Growth (at Birth)
Gestational age at term at term at term
Height 54 cm (75th–90th) 49 cm (25th–50th) 52.07 cm (75th)
Weight 3,925 g (50th–75th) 3,030 g (25th–50th) 3,580 g (50th–75th)
OFC 34 cm (50th–75th) 34 cm (50th–75th) not available
Growth (at Last Evaluation)
Height 78 cm (90th–97th) 104 cm (50th) 117.7 cm (10th)
Weight 9.0 kg (25th–50th) 15.5 kg (10th) 21.6 kg (10th)
OFC 43.5 cm (3rd–10th) 51.2 cm (25th) 51.5 cm (10th)
Development Delay
Global developmental delay þa mild speech delayb þc
Intellectual disability severe low average severe
IQ (scale) not applicable 85 (Griffiths) not available
Gross motor skills delayed not delayed delayed
Fine motor skills not applicable delayed delayed
Language delay not applicable mild þ
Abnormal behavior not applicable  þ
Neurological Features
Seizures/EEG anomalies EEG anomalies right focal clonic seizure with
secondary generalization
tonic clonic seizure
Hypotonia þ  þ
Hyperreflexia þ  not available
Intention tremor   þ
Visual impairment nystagmus with bilateral
optic hypoplasia
 nystagmus with bilateral
optic hypoplasia
Craniofacial
Bitemporal narrowing þ þ 
Blushy eyebrow þ þ þ
Straight eyebrow þ þ þ
Long eyelashes þ þ þ
Low-set ears þ þ 
Deep philtrum þ þ 
Short philtrum þ þ 5
Everted upper lip þ þ þ
Thin upper lip þ þ þ
Prominent upper vermilion þ þ þ
(Continued on next page)
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Table 1. Continued
Subject 1 Subject 2 Subject 3
Prominent lower vermilion þ þ þ
Large mouth  þ þ
Micrognathia/receding chin þ þ þ
Other   Pierre Robin sequence
Musculo/Skeletal Anomalies
Brachydactyly   þ
Skin/Ectodermal Features
Generalized hypertrichosis þ þ þ
Thick hair þ þ þ
Gingival overgrowth þ þ þ
Nail dysplasia   
aThe subject did not reach any milestone at the age of the last evaluation.
bMajor developmental milestones were achieved within proper age (head control, 3 months; sitting, 7 months; walking, 12 months; single words, 18 months).
cMajor developmental milestones were delayed (head control, 5 months; crawling, 1 year; walking, around 3 years; single words, 8 years).(ID), and epilepsy, and carrying the previously identified
GenBank: NM_001317090.1 (c.515C>A) as a de novo event
in the same gene, was found by using the web tool
GeneMatcher.22 In this subject, targeted enrichment was
attained using the IDT xGen Exome Research Panel v1.0
(affected subject and both parents), and sequencing was
performed using a HiSeq4000 platform (Table S1). WES
data analysis was performed as previously reported,23
taking into account the general assertion criteria for variant
classification available on the GeneDx ClinVar submission
page (submitter code 26957). Variant validation was
confirmed by Sanger sequencing. The two variants had
not been reported in ExAC/gnomAD, affected residues are
conserved among vertebrate orthologs, with Ala244 invari-
antly occurring among members of the TRAAK/TREK
subfamily (Figure S1), and were predicted to have a
damaging impact on protein function by CADD and
M-CAP algorithms (Table S1). In all subjects, WES data
analysis excluded the presence of functionally relevant
variants compatible with known Mendelian conditions
based on the expected inheritance model and clinical
presentation (Table S2).
K2P channels are dimeric proteins, with each subunit
contributing two pore domains to the channel
(Figure 2A).13,14,24 Based on available structures of KCNK4,
both affected residues mapped in regions possibly involved
in KCNK4 activation,25–29 with Ala244 located at the center
of helix M4 and Ala172 in M3, in a region of the helix with
extensive interaction with M2. Different models of
TRAAK/TREK channel gating have been proposed.24,27,30-32
According to one hypothesis, channel opening appears to
be mediated by a conformational transition of helix M4,
causing the closing of two lateral fenestrations exposing
the ion-conduction pathway to the hydrophobic core of
the lipidmembrane.27,33WhenM4 is straight (‘‘down’’state)
(Figure 2B), lipid moieties can insert in the lateral fenestra-624 The American Journal of Human Genetics 103, 621–630, Octobetion, thus blocking Kþ flow (inactive conformation).
BendingofM4 (‘‘up’’ conformation) closes the fenestrations,
preventing lipid insertion, and leading to a conducting state
of the channel.27 In alternative models, channel activation
involves conformational transitions at the selectivity fil-
ter.24 However, the possibility that multiple mechanisms
may contribute to the control of Kþ flux in response to
different stimuli cannot be ruled out. To explore the struc-
tural consequencesof thep.Ala172Gluandp.Ala244Pro sub-
stitutions, molecular dynamics simulations were performed
(SupplementalMethods), starting fromthe structureofwild-
type KCNK4 with one of the M4 helices (M4_B) in the up
state (PDB: 4WFE)27 embedded in a lipid bilayer. In agree-
ment with the lateral fenestration-based model of gating,
during the trajectory performed in the absence of channel-
activating stimuli, theM4_Bhelix of thewild-type (WT)pro-
tein evolved toward the down conformation (the same
straight structure was maintained for the M4_A helix)
(Figure S2). Down conformations were populated by both
helices also in the p.Ala172Glu mutant. In contrast, in the
p.Ala244Pro channel, bothhelices attained anupconforma-
tion, in agreement with the helix-breaking properties of Pro
residues.34 The effect of the amino acid substitutions on the
opening/closing of lateral fenestrations was also investi-
gated. The lateral fenestrations were significantly less open
in the p.Ala244Pro and p.Ala172Glu mutants compared to
the WT protein (Figure 2C). By taking a reference value of
2 A˚ (i.e., the size of a methane molecule to represent the
size of a lipid chain) as cut-off, the lateral fenestrations of
WT, p.Ala172Glu, and p.Ala244Pro structures were open
for 27%, 12%, and 0.2% of the time, respectively. In the
model of gating based on lateral fenestrations, this finding
suggests basal activation in both mutants. By contrast,
no significant differences were observed in the selectivity
filter region (Figure S3). Of note, in the simulation of
p.Ala172Glu, the lateral fenestrations were closed for ar 4, 2018
Figure 2. KCNK4 Structure and Location
and Structural Consequences of Disease-
Causing Mutations
(A) KCNK4 is a homodimeric channel. The
schematic structure of the monomer is
shown with the cytoplasmic side pointing
down (left). Each subunit comprises an
extracellular cap covering the pore, four
transmembrane helices (M1 to M4), and
two pore domains (P1 and P2) constituting
the selectivity filter. Kþ ions are shown as
white spheres. Locations of mutated resi-
dues are highlighted by pink spheres. The
crystallographic structure of the KCNK4
dimer (PDB: 4WFF) is also shown (lateral
view, middle; as seen from the cytoplasm,
right). One monomer is colored with the
same code of the scheme, while the other
monomer is reported in gray.
(B) Structure of the KCNK4 channel in the
two conformational states with open and
closed lateral fenestrations (PDB: 4WFF
and 4WFE, left and right panels, respec-
tively). Only helix M4 and residue Ala244
are highlighted in dark red and pink,
respectively. Kþ ions are shown as white
spheres, while the decane molecule in-
serted in the lateral intramembrane fenes-
tration and blocking the channel is shown
as blue spheres. The protein is reported in
both ribbon and surface representations,
to illustrate the open and closed states of
the fenestration that allow or avoid the
entrance of the aliphatic molecule.
(C) Structural impact of the p.Ala244Pro and p.Ala172Glu amino acid substitutions, as observed in the molecular dynamics (MD)
simulations. Histograms of the pore radius of the two lateral openings, observed in the MD simulations (p.Ala244Pro [green],
p.Ala172Glu [orange], andWT [red]) (left). The vertical dashed line indicates the radius of a methanemolecule (2.0 A˚). Lateral opening
in the conformation that best represents those observed in the MD simulations are also shown (right). The fenestration is viewed from
the lipid-exposed external surface and helicesM4 andM2 are shown in transparency. Residues Leu125, Phe246, and Leu250 involved in the
hydrophobic cluster occluding the fenestration are shown in ball-and-stick representation.significant fraction of the trajectory, even though both heli-
ces were in the down conformation (Figure 2C), suggesting
that sealing of the lateral openings is more complex than
simplehelix bending.27 This occlusion resulted from the for-
mationof a hydrophobic cluster involving the side chains of
Leu125, Phe246, and Leu250. In the p.Ala172Glu mutant, the
substitution induced the formation of an inter-domain salt
bridge between Glu172 (M3 helix) and Arg147 (M2 helix)
(Figure S4). The strengthened salt bridge network between
the M2 andM3 helices might be responsible for the closing
of the fenestration, due to the multiple interactions among
helices M2, M3, and M4.
To investigate experimentally the predicted activating ef-
fect of the two identified KCNK4 mutations, their impact
on protein function was assessed by patch-clamp experi-
ments (SupplementalMethods) in transfectedChineseham-
ster ovary (CHO) cells. Nucleotide substitutions resulting in
the p.Ala244Pro and p.Ala172Glu amino acid changes were
introduced into theKCNK4 cDNA (cloneKT4.1a) cloned in a
pcDNA3 vector (Invitrogen), using the QuikChange Site-
Directed Mutagenesis Kit (Agilent Technologies). Cells
were transfected with WTor mutant human KCNK4 cDNA
(400 ng/mL or 80 ng/mL as final concentration; co-expres-
sion assays: 80 ng/mL, each channel plasmid, resulting in aThe Americatotal of 160 ng/mL channel cDNA), and cDNA encoding
EGFP-N1 (Clontech), using Lipofectamine 2000 (Invitro-
gen). In the whole-cell mode, we recorded outward-recti-
fying currents in cells expressingWTKCNK4,whichbecame
evident at positive potentials. Membrane currents recorded
from cells transfected with the mutant channels were
much larger andalreadyprominent in thenegativepotential
range (Figures 3A and 3B). p.Ala244Pro KCNK4 channels
mostly lacked a voltage-dependent initial current increase,
resembling maximally stimulated WT KCNK4 channels.32
Voltage ramps were used to evaluate current amplitude at
0 mV and conductance at 80 mV, encompassing the
most important physiological voltage range. Expression of
the mutant KCNK4 channels, as well as their co-expression
withWT KCNK4, resulted in significantly increased current
amplitudes compared to WT channels (Figures 3C, 3D, and
S5), documenting the dominant impact of mutations. Cur-
rent reversal was close to 80 mV and demonstrated pre-
served Kþ selectivity of both mutant channels. Since the
whole-cell mode is regarded as the only configuration of
the patch clamp-technique that exerts no tension on the
cellmembrane,35 the observed differences reflect an impres-
sive gain of function of the mechanically unstimulated
KCNK4 channel induced by both point mutations.n Journal of Human Genetics 103, 621–630, October 4, 2018 625
Figure 3. Whole-Cell Current Recordings from CHO Cells Expressing Wild-Type or Mutant KCNK4 Channels
(A) Representative current recordings elicited with the indicated pulse protocol consisting of 100 ms voltage steps to potentials between
110 and 100 mV in cells expressing the wild-type (WT) or mutant (p.Ala244Pro or p.Ala172Glu) KCNK4 channels.
(B) The I/V-plot shows means5 SEM of current amplitudes recorded with the voltage step protocol. Number of experiments is given in
parentheses. Cell transfections were performed using a 1:10 predilution of KCNK4 cDNA (final concentration 400 ng/mL).
(C) I/V-plots of representative KCNK4 current recordings elicited with the ramp protocol shown as inset. Cells were previously
transfected or co-transfected with cDNA coding for WT and mutant KCNK4 cDNA using a predilution of 1:50 for each channel cDNA
(final concentration 80 ng/mL and for co-transfection, a total of 160 ng/mL).
(D) Means 5 SEM of the current amplitude at 0 mV ramp potential. One-way ANOVA with post hoc Bonferroni t testing yielded
significant (**p < 0.01, ***p < 0.001) differences compared to WT data.
A more detailed analysis of the whole-cell coexpression experiments is shown in Figure S5.Mechanosensitivity of the different KCNK4 channels
was investigated in outside-out experiments. WT KCNK4
channels were activated by positive pressure applied
through the patch pipette, and the effect often increased
with repetitive stimulation and with time (Figures 4A
and 4B). Maximal activation resulted in an increase in
current amplitudes to almost hundredfold of the initial
value (Figures 4C and 4D). In most experiments, the Kþ
current generated by maximally activated WT KCNK4
channels in the small membrane patch exceeded the
amplitude of the corresponding whole-cell current.
Outside-out patches from cells expressing each of the
KCNK4mutants exhibited higher initial current amplitude
at 0 mV and higher basal Kþ conductance. Remarkably,
the effect of pressure stimulation was significantly
impaired in patches containing these mutants (Figures 4
and S6). Pressure-induced changes in current amplitude
were absent in most experiments on p.Ala244Pro KCNK4
channels, and only a small increase in current amplitude
with pressure application was documented for the
p.Ala172Glu mutant. Coexpression experiments with WT
and p.Ala172Glu KCNK4 channels resulted in slightly
more pronounced pressure-induced channel activation,626 The American Journal of Human Genetics 103, 621–630, Octobebut the effects were significantly smaller than for the WT
channels (Figure S6C).
In addition to their mechanosensitivity, K2P channels
of the TRAAK/TREK subfamily are sensitive to certain
lipids.12,13 Specifically, KCNK4 is activated by arachidonic
acid and polyunsaturated fatty acids. Accordingly, applica-
tion of a high concentration of arachidonic acid (20 mM)
resulted in a huge increase inWTKCNK4 currents recorded
in the whole-cell configuration (Figures 5A and 5D). Using
the identical experimental approach, both KCNK4
mutants were found to lack the impressive channel activa-
tion in response to arachidonic acid (Figures 5B–5D),
which likely reflects their maximal activation basally.
Measurements in the cell-attached configuration with
undisturbed intracellular milieu and intact cytoskeleton
gave qualitatively similar results (Figures S7A–S7C), further
supporting the gain of function of the unstimulated
mutant channels and their impaired mechanosensitivity.
Of interest, the I/V relation showed pronounced inward
rectification in most cell-attached measurements with
the p.Ala244Pro mutant, while this feature was rarely
(p.Ala172Glu) or never (WT) observed in cells expressing
the other KCNK4 channels (Figures S7D and S7E). Asr 4, 2018
Figure 4. Current Recordings in theOutside-Out Patch-ClampConfiguration fromCHOCells ExpressingWild-Type orMutant KCNK4
Channels
(A) Overlay of I/V plots of membrane currents repeatedly elicited by the illustrated ramp protocol with intermittent application of
positive pressure. Data of a representative experiment on a cell expressing wild-type (WT) KCNK4 (both left) and data of experiments
with p.Ala244Pro or p.Ala172Glu KCNK4 channels (right).
(B) Time course of current amplitudes measured at 0 mV ramp potential with intermittent mechanical stimulation; data correspond
to the three experiments shown in (A). The filled symbols indicate the illustrated I/V traces. Please note the logarithmic scale used to
visualize the time- and pressure-dependent changes.
(C) Analysis of current recordings directly after the establishment of the outside-out configuration. Boxplot of the current amplitudes
at 0 mV ramp potential. Data from experiments with cDNA predilution 1:10 for WT KCNK4 (n ¼ 10) and the p.Ala244Pro (n ¼ 11)
and p.Ala172Glu (n ¼ 15) KCNK4 mutants.
(D) Analysis of maximal time- and pressure-induced changes in KCNK4 current amplitudes. Combined data from experiments using
1:10 or 1:50 cDNA predilution for transfection (WT KCNK4, n ¼ 16; p.Ala244Pro, n ¼ 13; p.Ala172Glu, n ¼ 19). Fold current increase
was calculated for each experiment as ratio of the maximal (with pressure) to the initial (without pressure) current amplitude at 0 mV.
Please note the logarithmic scale of this parameter. Bot plot whiskers (C and D) indicate the 10/90 percentiles.
Statistical analysis (C and D): Kruskal-Wallis tests yielded significant differences between groups (ANOVA on ranks: p < 0.001); post
hoc Dunn’s testing yielded significant differences compared to WT data; significance levels were determined with the Wilcoxon-
Mann-Whitney test (***p < 0.001). A more detailed analysis of the outside-out experiments is shown in Figure S6.inward rectification of activated KCNK channels with
inverted Kþ concentration gradient has been reported,32
the degree of inward rectification is likely to mirror the
level of intracellular Kþ depletion. Deleterious effects of
substantial Kþ loss associated with high p.Ala244Pro
KCNK4 expression levels are suggested by a lack of cells
with bright EGFP fluorescence (Figure S7F). This ‘‘negative
selection’’ most probably biased the results of the electro-
physiological measurements, leading to an underestima-
tion of the channel-activating effect promoted by the
p.Ala244Pro substitution. Overall, the functional data are
in agreement with the MD findings, and similarly to
mechanical stimulation,27,28,31 both mutations are sug-
gested to result in enhanced closing of the lateral fenestra-
tions, favoring channel opening. This can readily explain
the high basal activity, as well as the impaired mechano-The Americasensitivity of the mutant channels. Of note, also arachi-
donic acid failed to activate the disease-causing mutant
channels, suggesting that both mutations promote activa-
tion of the channel basally, which cannot be further
increased by stimuli involving a similar mechanism of
channel activation.
While the role of K2P channels in controlling the mem-
brane potential makes them potential players in a wide
array of cellular processes, only subtle alterations in phys-
iologic processes have been linked to dysfunction of
these channels.36 Our findings provide evidence that
gain-of-function mutations in KCNK4 cause a distinctive
neurodevelopmental syndrome, for which we propose
the acronym FHEIG (facial dysmorphism, hypertrichosis,
epilepsy, intellectual disability/developmental delay, and
gingival overgrowth). While additional case subjects aren Journal of Human Genetics 103, 621–630, October 4, 2018 627
Figure 5. The Basally Activated
p.Ala244Pro and p.Ala172Glu KCNK4 Mu-
tants Do Not Further Respond to Arachi-
donic Acid (AA) Stimulation
(A–C) I/V-plots of current traces recorded in
the whole-cell configuration with a ramp
protocol (beneath A) from cells previously
transfected with cDNA coding for wild-
type (WT) KCNK4 (A; cDNA predilution
1:10), and p.Ala244Pro (B) or p.Ala172Glu
(C) KCNK4 (each mutant: cDNA predilu-
tion 1:50). Control current traces (just
before application of AA) and traces illus-
trating maximal current amplitudes after
application of 20 mMAA are superimposed.
(D) Analysis of AA-induced changes.
Results are presented as box plot (whiskers
indicate the 10/90 percentiles). Please
note the logarithmic scale. Application of
20 mM AA resulted in a slowly developing,
impressive activation of WT KCNK4 chan-
nels (maximal current amplitude at 0 mV
in the time period 2–20 min after AA appli-
cation relative to the value just before AA
application is given as fold current increase;
median ¼ 66.7). Both mutant channels
showed a significantly impaired response
to AA (p.Ala244Pro, fold current increase:
median ¼ 1.12; p.Ala172Glu, fold current
increase: median ¼ 1.06). Asterisks denote
significant differences compared to WT
data (ANOVA on ranks and post hoc
Dunn’s testing; ***p < 0.001).required to delineate more accurately the clinical vari-
ability associated with activating KCNK4 mutations, the
specific association of features and distinctive facies sup-
port the view that this condition represents a novel
nosologic entity. Based on the three identified affected sub-
jects, the major features characterizing this disorder are
reminiscent of the phenotypic continuum associated
with activating mutations in the voltage-gated Kþ channel
KCNH1 (MIM: 603305)8,9 and disorders caused by muta-
tions in ABCC9 (MIM: 601439) and KCNJ8 (MIM:
600935), two genes encoding ATP-sensitive potassium
channel subunits with defective function in Cantu` syn-
drome.10,11 In subjects with KCNK4mutations, the clinical
phenotype is characterized by a significant evolution of
the craniofacial features with age, and the condition
should be considered in differential diagnosis with other
disorders (Table S3). Neonatally, it resembles Wiede-
mann-Steiner syndrome (MIM: 605130) to some extent,
while later the phenotype becomes more similar to
Temple-Baraitser syndrome (MIM: 611816) andmild forms
of Cantu` (MIM: 239850) and Coffin-Siris (MIM: 135900)
syndromes. Similarly to what is observed in these syn-
dromes, the three affected subjects with de novo KCNK4
mutations show variable developmental delay and cogni-
tive impairment, ranging from a mild speech delay and
disorganized pattern of development (individual 2) to an
extremely severe ID (individual 1). In contrast to other
K2P channels, KCNK4 appears to be almost exclusively
expressed in neuronal cells of the central and peripheral628 The American Journal of Human Genetics 103, 621–630, Octobenervous system and in the retina (see GTEx database); so,
the finding of its pleiotropic impact is unexpected. In
rodent peripheral somatosensory neurons, KCNK4 appears
to modulate thermo- and mechano-sensation and the
respective threshold to nociception.37 Laser-evoked poten-
tials assessed in subjects 1 and 2 did not provide any
aberrant pattern, suggesting no gross dysregulation of
temperature and pressure sensitivity.
Depending upon the gating behavior of a given Kþ chan-
nel and its cellular and subcellular expression profile in the
brain, intellectual impairment and seizures can result
from either loss-of-function or gain-of-function muta-
tions.2,5,7–11,38 Notably, gingival overgrowth is a major
feature in subjects with gain-of-function mutations in
KCNH1,8,9 KCNQ1,39 and KCNK4 (present study), which
consistently result in significantly elevatedKþ conductance
at more negative potentials. Of note, Kcnk4/ mice
exhibit neither obvious developmental abnormalities nor
increased susceptibility to seizures or deficits in cognition,
touch, vision, and hearing.40 Thus, loss of KCNK4 function
is likely compensated for by other members of the K2P
family or its relevance is limited to pathophysiological con-
ditions like brain ischemia.41,42 Accordingly, the two dis-
ease-causing KCNK4 mutations resulted in an impressive
gainof function, indicatedby adramatically increasedbasal
Kþ conductance. Of note, the sustained high Kþ conduc-
tance responsible for the clinical features and symptoms
observed in FHEIG syndrome is expected to drain Kþ out
of cells that exhibit considerable depolarizing currents.r 4, 2018
This can result in intracellular Kþ depletion and increased
interstitial Kþ concentration, with a depolarizing effect
also on neighboring cells.
Taken together, our findings characterize a channelop-
athy that is caused by hyperactivation of KCNK4 channels.
While the molecular mechanisms controlling K2P channel
function are still subjects of debate, the present in silico and
in vitro data consistently support the relevance of the
closing of lateral fenestrations to channel gating,24,43 and
suggest that helix bending is not the only conformational
transition controlling the state of lateral fenestrations in
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